Skip to content

Consumer exposure to oxidative hair dyes. A [14C]-PPD labelled mass balance study.

Consumer exposure to oxidative hair dyes. A [14C]-PPD labelled mass balance study. - PPD absorption from hair dye

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30980
Enrollment
16
Registered
2007-06-12
Start date
2007-06-12
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nvt. dit is een veiligheidsonderzoek systemic absorption

Interventions

A single typical hair dye procedure per subject will be performed by a professional hairdresser. Four hairdressers will be involved in the study.

Sponsors

L'Oreal R&D, Worldwide Safety Evaluation
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1:Female/Male; Age 18-45 years; 2:Healthy as assessed by health questionnaire, physical examination, clinical chemistry 3:A pregnancy test (dipstick in urine) 4:Having given their written informed consent 5: Willing to have their coloured hair completely clipped (bald headed!) 6:Willing to use adequate measures to avoid pregnancy during the whole study (females only) 7:Willing to refrain from hair cutting (2-3 months) and to let grow their hair to about a 5 cm length on Day01

Exclusion criteria

Exclusion criteria: 1: Participation in any clinical trial or medical treatment including administration of a radiolabelled test substance up to 1 year before Day 01 of this study 2: Positive pregnancy test (urine) (females) 3: Prescribed medication (except oral contraceptives and paracetamol) 4: Having a known allergy to PPD 5: Having a positive response to the retroauricular sensitisation test to PPD, conducted 2 days in advance of Day 01 of the study

Design outcomes

Primary

MeasureTime frame
The individual concentration versus time courses of [14C]-radioactivity (recoveries) in all non-biological samples will be established and expressed as percentages relative to the applied dose. For biological (blood and urinary) samples, results will also be expressed as [14C]-PPDeq or as [14C]-PPDeq per unit of mass (g) or volume (mL).

Secondary

MeasureTime frame
Establishing a Mass balance

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)